-
-
-
-
-
-
-
Canaccord Genuity Starts Veru, Inc. (VERU) at Buy
-
-
-
-
-
-
-
Veru selects Laxxon's SPID technology for enobosarm formulation
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
-
-
413,555 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

